Showing results (561-570 of 3,318) with videos related to
Sort By:
Pageof 332
Journal of Clinical Psychopharmacology|June 1, 1988
Treatment of negative schizophrenic symptoms with trihexyphenidylR Tandon, J F Greden, K R SilkJournal of Clinical Psychopharmacology|March 30, 2021
Combined Oxytocin and Cognitive Behavioral Social Skills Training for Social Function in People With SchizophreniaRobert W Buchanan, Deanna L Kelly, Gregory P Strauss, et al.Journal of Clinical Psychopharmacology|April 12, 2021
Effects of Ayahuasca on the Recognition of Facial Expressions of Emotions in Naive Healthy Volunteers: A Pilot, Proof-of-Concept, Randomized Controlled TrialJuliana Mendes Rocha, Giordano Novak Rossi, Flávia de Lima Osório, et al.Journal of Clinical Psychopharmacology|August 23, 2020
Risk of Prolonged Corrected QT Interval With Amisulpride Therapy for Renal Function Management in Patients With SchizophreniaBinbin Chen, Chen Wang, Xiangzhen Xu, et al.Journal of Clinical Psychopharmacology|July 9, 2020
Correlates of the Abnormal Involuntary Movement Scale in Veterans With Tardive DyskinesiaStanley N Caroff, Shirley H Leong, Christopher B Roberts, et al.Journal of Clinical Psychopharmacology|July 9, 2020
Antidepressant Augmentation: A Review of the Literature and a Review of the Pharmacoeconomic ConsiderationsGlenn Catalano, Rhonda A Robeel, Grace A Cheney, et al.Journal of Clinical Psychopharmacology|July 9, 2020
Free Testosterone and Prolactin Levels and Sperm Morphology and Function Among Male Patients With Tramadol Abuse: A Case-Control StudyMedhat M Bassiony, Usama M Youssef, Hayam El-GohariJournal of Clinical Psychopharmacology|April 27, 2021
Dose-Dependent Inhibition of CYP2D6 by Bupropion in Patients With DepressionKristine Hole, Marianne Arnestad, Espen Molden, et al.Journal of Clinical Psychopharmacology|July 16, 2008
Short-term testosterone augmentation in male schizophrenics: a randomized, double-blind, placebo-controlled trialYoung-Hoon Ko, Young-Min Lew, Sung-Won Jung, et al.Journal of Clinical Psychopharmacology|July 16, 2008
Standard and higher dose of olanzapine in patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, fixed-dose studyBruce J Kinon, Jan Volavka, Virginia Stauffer, et al.Pageof 332